OpenEquity Research
  • Home
  • News
No Result
View All Result
Request Research
  • Home
  • News
No Result
View All Result
OpenEquity Research
No Result
View All Result

SKYX to Host Virtual Investor Event to Discuss New Developments on Thursday, November 17, at 11:00am Eastern

by
November 16, 2022

Miami, FL, November 14, 2022 – SKYX Platforms Corp. (NASDAQ:SKYX) (d/b/a "Sky Technologies") ("SKYX," "we" or "the Company"), a highly disruptive platform technology company with over 60 issued and pending patents globally for simplifying and enhancing safety and automation in homes and buildings, today announced that it will host a virtual investor event on Thursday, November 17, 2022, at 11:00am Eastern. The event will include a question and answer session, and interested parties can register for the event here.

SKYX Virtual Investor Event:

Date: Thursday, November 17, 2022
Time:
11:00am Eastern time
Webcast Link:
https://viavid.webcasts.com/starthere.jsp?ei=1583575&tp_key=f045c6c25d

The presentation will be posted to the investor relations website the day of the event and an archived replay will be available at the above link shortly after the event concludes.

About SKYX Platforms Corp.

As electricity is a standard in every home and building, our mission is to make homes and buildings become safe-advanced and smart as the standard.

SKYX Platforms Corp. (NASDAQ: SKYX) has a series of highly disruptive advanced-safe-smart platform technologies, with over 60 U.S. and global patents and patent pending applications. Our technologies place an emphasis on high quality and ease of use, while significantly enhancing both safety and lifestyle in homes and buildings. We believe that our products are a necessity in every room in both homes and other buildings in the U.S. and globally. For more information, please visit our website at https://skyplug.com or follow us on LinkedIn.

Investor Relations Contact:

Lucas A. Zimmerman

MZ North America

(949) 259-4987

SKYX@mzgroup.us

Previous Post

Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. Announce Manufacturing and Research Partnership

Next Post

Organicell Activates COPD Trial at Mayo Clinic

Next Post
Organicell Activates COPD Trial at Mayo Clinic cover

Organicell Activates COPD Trial at Mayo Clinic

Subscribe

CONGRATULATIONS!!

These Next Steps are EXTREMELY IMPORTANT because the only way to get our Featured Top Stock Alerts is to reply back to the message you just received by answering YES.

CLICK HERE TO REPLY BACK
YES ON YOUR CELL PHONE

To make sure you are in, please check your cell phone for a message from 16462224464 (make sure you save that number on your contacts under "StockTips") If you don't see the message check "Unknown Senders" on your phone.

If you did not receive the text message on your cell phone, then grab your phone right now and text the word "MOMO" to "16462224464"

✓ Valid
  • Home
  • News
  • Requests
  • Disclaimer
OpenEquity Research

© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.

Would you like to meet the CEO?
No Result
View All Result
  • Home
  • News
  • Requests
  • Disclaimer

© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.